Voya Investment Management Reduces $47M in Astera Labs, Inc. ($ALAB)
Voya Investment Management reduces its stake in Astera Labs by over 43%, according to the latest 13F filing.
Key Points
- Voya Investment Management cut its Astera Labs stake by 43.4%, reducing its holdings by 95,324 shares to 124,304 shares as of the latest 13F filing.
- Astera Labs, trading near $494.4, has a market cap of $82.8 billion and a P/E ratio of 330.8, with a 52-week range between $85.85 and $499.48.
- Insiders at Astera Labs, including Bethany Mayer and Jack Lazar, sold shares in June, while analysts maintain varied ratings with price targets ranging from $200 to $460.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Voya Investment Management has reduced its stake in Astera Labs, Inc. (NasdaqGS: ALAB) by 43.4%, according to its latest 13F filing with the SEC. The firm sold 95,324 shares, bringing its total holdings to 124,304 shares valued at approximately $61.5 million as of the reporting period.
Voya Investment Management vs. the S&P 500
Hypothetical, simulated performance of disclosed positions vs. the S&P 500. Not realized profit and not investment advice. Past performance does not indicate future results. Details.
What Changed in Voya Investment Management's Astera Labs Position
Voya Investment Management significantly trimmed its position in Astera Labs, decreasing its holdings from 219,628 shares to 124,304 shares. This reduction of 95,324 shares represents a 43.4% decrease in its investment, reflecting a strategic adjustment in its portfolio.
Other Institutional Activity in Astera Labs
FMR LLC increased its holdings in Astera Labs by 194,944 shares, now holding 25,529,885 shares valued at about $2.8 billion, marking a modest 0.8% increase. In contrast, BlackRock, Inc. reduced its position by 1,519,089 shares, representing an 11.7% decrease, leaving it with 11,449,769 shares worth approximately $1.25 billion. Vanguard Portfolio Management LLC and Vanguard Capital Management LLC both opened new positions, acquiring 7,309,778 and 6,340,732 shares, respectively. Atreides Management, LP boosted its stake by 1,754,593 shares, a 108.9% increase, to a total of 3,365,787 shares valued at $368.9 million.
Astera Labs, Inc. Stock Up 70.8%
As of Wednesday, shares of Astera Labs were trading around $494.4. The company boasts a market capitalization of $82.8 billion and a high P/E ratio of 330.8, indicating strong investor expectations for future growth. Its forward P/E is more moderate at 112.1. Astera Labs exhibits a high beta of 3.963, suggesting significant volatility compared to the broader market. The stock’s 52-week price range spans from $85.85 to $499.48, with a 50-day moving average of $288.5 and a 200-day moving average of $192.5.
$ALAB stock price
Daily closing prices, year to date. Not investment advice.
Recent Earnings
Astera Labs reported revenue of approximately $1 billion, with a robust growth rate of 93.4%. The company achieved a net margin of 26.7% and a return on equity of 21.1%. Earnings per share stood at $1.46. The next earnings report is scheduled for August 4, 2026.
Earnings drift grade
Outlook vs expectations on the last report — not price action.
-
Forward outlook
10 analysts raised price targets.
-
EPS & revenue
EPS beat estimates by 11.6%. Revenue beat estimates by 3.5%.
-
Profit surprise
EBITDA missed by 34 percent. Operating income missed by 40 percent.
-
Pre-earnings setup
Bar was high, analysts already very bullish.
-
Analyst signal
10 target raises.
-
Earnings quality
Gross margin up 1.4 points. Operating margin up 13.0 points.
Earnings Call Summary
Astera Labs delivered strong Q1 results with revenue of $308 million, up 93 percent year over year, driven by broad growth across signal conditioning and fabric switch products. PCIe Gen 6 products contributed over one third of total revenue. The company shipped initial production volumes of the new Scorpio X 320-lane switch and is expanding optical capabilities through the XScale acquisition, with near-package optics expected to ship in 2027 and chiplet-package optics in 2028.
Guidance Management expects revenue between $355 million and $365 million in the next quarter, up 15 to 18 percent sequentially. They expect non-GAAP earnings per share between $0.68 and $0.70, with gross margin around 73 percent before a one-time customer agreement charge. The Scorpio product line is expected to become their largest business by year end.
Slightly positive report. The quarter was acceptable, but the forward setup is not strong.
Insider Buying and Selling at Astera Labs, Inc.
In June, several insiders at Astera Labs engaged in notable stock transactions. Bethany Mayer sold 686 shares at an average price of $395.04 in a planned sale on June 24. Earlier in the month, on June 4, Jack Lazar sold 10,000 shares at $355.17 per share in a planned transaction. On the same day, Craig Barratt, Michael Hurlston, and Bethany Mayer each acquired 837 shares, though the transactions were not planned.
Analysts Set New Price Targets
On June 29, UBS maintained its hold rating on Astera Labs with a price target of $400. Stifel reaffirmed its buy rating on June 24, setting a target of $460. B of A Securities also maintained a hold rating with a $450 target on June 23. The consensus among analysts is a buy recommendation, with an average target price of $272.47 based on 22 opinions.
About Astera Labs
Astera Labs, Inc. is a technology company based in San Jose, California, specializing in semiconductor-based connectivity solutions for cloud and AI infrastructure. Founded in 2017, it designs and manufactures products that integrate microcontrollers and sensors, offering a range of connectivity solutions like PCIe/CXL retimers and smart cable modules. The company serves major customers in the hyperscale and OEM sectors.
Bottom Line
Voya Investment Management's decision to cut its stake in Astera Labs highlights the dynamic nature of institutional investing. Investors keep a close eye on such 13F filings to gauge fund managers' confidence in a stock. While this filing shows past actions, it might not reflect current positions. Astera Labs remains a significant player in the semiconductor industry, with strong financials and active insider and analyst activity.
Get Astera Labs, Inc. alerts
New 13F filings, insider trades, and analyst moves on $ALAB, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.